Patient and Physician Behavior
Our work in Patient and Physician Behavior
-
Prescription Drug Monitoring Program Use by Opioid Prescribers: A Cross-Sectional Study
The research assessed PDMP use in Minnesota, which requires opioid prescribers to hold accounts and, in most cases, search the PDMP before prescribing, but where enforcement authority is limited
Categorized in -
Why Higher Copayments for Opioids Did Not Reduce Use Among Medicare Beneficiaries
Greater prescribing of opioids by physicians is widely understood to be the primary driver of the opioid epidemic. Ironically, the introduction of Medicare Part D contributed to the epidemic.
Categorized in -
Context Matters: Using an Evidence to Decision (EtD) Framework to Develop and Encourage Uptake of Opioid Deprescribing Guideline Recommendations at the Point-Of-Care
The context within which evidence-based recommendations are considered, as well the political and health-system environment, can contribute to the success of recommendation implementation.
Categorized in -
Small Town Strong
Directed by USC Price School alumnus Chase Millsap, the documentary “Small Town Strong” chronicles how the people of Portsmouth, Ohio, banded together to take on the deadly fentanyl epidemic through fitness. After screening the documentary, a panel discussion with the filmmakers and USC Price School faculty will discuss the themes of the opioid crisis, addiction […]
-
America’s Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms
This study can help researchers better consider the full consequences of policy changes and help members of the media identify the dynamics of interactions that deserve more attention.
Categorized in -
A Clinical Pathway to Well-Being: Putting Patient Priorities at the Center of Care
Using a patient’s self-defined goals can be a powerful motivator for improving health outcomes.
Categorized in -
Centers for Disease Control and Prevention Guideline for Prescribing Opioids, 2022—Need for Integrating Dosing Benchmarks with Shared Decision-Making
A fully individualized, unstructured decision-making process
will not be adequate to protect patients receiving long-term opioid
therapy.Categorized in -
Why Doctors Using ChatGPT Are Unknowingly Violating HIPAA
USC Schaeffer Center senior fellow Genevieve Kanter says the risk to patient privacy posed by AI chatbots presents unique challenges.
Categorized in -
Is Exposure to Pharmaceutical Direct-to-Consumer Advertising for Heart Disease and Diabetes Associated with Physical Activity and Dietary Behavior?
Widespread exposure to such DTCA is associated with higher levels (though small in magnitude) of consuming alcohol, fast food, candy, and sugar-sweetened beverages.
Categorized in -
Health Care Privacy Risks of AI Chatbots
Ultimately, health systems facing increased risk of AI chatbot breaches must decide whether to discourage clinicians’ use of this technology or embrace it.
Categorized in